About

This company specializes in early cancer detection through its flagship product, the Galleri Test, which employs cutting-edge methylation technology and machine learning algorithms to analyze abnormal methylation patterns on cell-free DNA, indicative of over 50 cancer types. The focus on groundbreaking healthcare solutions and the utilization of advanced technology offers a highly collaborative and intellectually stimulating work environment. This makes it an attractive workplace for those dedicated to enhancing cancer diagnostics and contributing to significant advancements in medical science.